Send to

Choose Destination
Dermatol Surg. 2008 Nov;34(11):1469-76. doi: 10.1111/j.1524-4725.2008.34311.x. Epub 2008 Sep 15.

Protection afforded by sunscreens containing inorganic sunscreening agents against blue light sensitivity induced by aminolevulinic acid.

Author information

Innovaderm Research Inc, Montreal, QC, Canada.



Application of aminolevulinic acid (ALA) for photodynamic therapy induces significant sensitivity to visible light.


To determine whether sunscreens containing inorganic agents are effective against sensitivity to blue light induced by ALA application.


Twenty subjects received application of ALA on the arm. Thirty minutes before blue light exposure, two sun protection factor 50 inorganic-based sunscreens containing iron oxide 3.2% and 0.2% were applied on separate areas where ALA was applied; a third area received no sunscreen. Small areas of skin were exposed to increasing fluences of blue light 3 or 18 hours later, and the minimal phototoxic dose (MPD) was noted.


Three hours after ALA application MPD was 29.2 and 22.6 J/cm(2) for skin protected with sunscreen containing iron oxide 3.2% and 0.2%, respectively, and 10.6 J/cm(2) for unprotected skin (p=.003 and .0497 respectively). At 18 hours after ALA application, MPD for sunscreen containing iron oxide 3.2% was 5.78, compared with 0.33 for unprotected skin (p<.001) with a blue light protection factor of 21.


The sunscreen containing iron oxide 3.2% afforded significant protection against blue light sensitivity induced by ALA application.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center